Nicotine Science and Policy
By Harry Shapiro July 10, 2026
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.
July 03, 2026 by reason.org
Southern California’s total tobacco bans aren’t helping public health
Southern California’s total tobacco bans raise serious questions about whether prohibition is improving public health or simply shifting behaviour elsewhere. When legal access is removed, consumers may turn to neighbouring markets, illicit sellers or more harmful products that remain easier to obtain. Policies aimed at reducing harm should be judged by real-world outcomes, not symbolic restrictions. Effective regulation should protect young people while preserving realistic pathways away from combustible tobacco.
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
July 02, 2026 by johnmenadue.com
Switching from a failed vape and tobacco policy to a successful one
Australia’s vape and tobacco policy shows the cost of making safer products harder to access than cigarettes. Legal vapes are restricted through pharmacies, while combustible tobacco remains widely available, leaving smokers with fewer practical routes away from the most harmful option. A successful policy would regulate nicotine by risk, protect young people and keep lower-risk alternatives in legal, accountable channels. Harm reduction should replace a system that is failing both smokers and public health.
July 02, 2026 by spiked-online.com
The nanny state is sanitising Britain to death
Britain’s generational smoking ban reflects a wider shift towards treating adults as problems to be managed rather than people capable of informed choice. Reducing smoking matters, but prohibition is a blunt tool that risks ignoring autonomy, pleasure and real-world behaviour. Harm reduction offers a better path: give people accurate information, preserve safer alternatives and reduce risk without sanitising life into submission. Public health should help adults make better choices, not remove choices altogether.
11.80% of the adult population are current smokers. There are approximately 6.7 million current smokers in United Kingdom 13.60% of men are current smokers but only 10.10% of women.
SOURCE: GSTHR
July 02, 2026 by realclearscience.com
On Nicotine, FDA Embraces Science and Delivers a Public Health Victory
The FDA’s authorisation of modified risk claims for ZYN nicotine pouches marks a public health win for evidence-based risk communication. It recognises a simple but often ignored fact: smoke-free nicotine products do not carry the same risks as combustible cigarettes. For adult smokers, clear information about lower-risk alternatives can support better decisions and more realistic routes away from smoking. Public health should follow the science, not blur all nicotine products into the same category.
July 01, 2026 by reuters.com
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The FDA’s decision to allow ZYN nicotine pouches to be marketed as less harmful than cigarettes is …
July 01, 2026 by fda.gov
FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim
The FDA’s authorisation of modified risk claims for 20 ZYN nicotine pouch products marks an importa…
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
July 02, 2026 by clearingtheair.eu
Ireland moves closer to banning fruit and sweet vape flavours
Ireland’s move towards banning fruit and sweet vape flavours risks weakening one of the features that helps adult smokers switch away from cigarettes. Flavours can make vaping more acceptable than smoking and help people distance themselves from the taste of combustible tobacco. Protecting young people is essential, but broad flavour bans may reduce the appeal of lower-risk alternatives for adults trying to quit. Better regulation should target youth access without removing tools that support smoking cessation.
17.00% of the adult population are current smokers. There are approximately 730,000 current smokers in Ireland 20.00% of men are current smokers but only 14.60% of women.
SOURCE: GSTHR
Blogs
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.
Harry’s Blog 131: Hidden harms
New publications from K•A•C discuss the challenge of smoking in treatment services caring for those who are HIV positive or coping with drug problems.
Smoking rates among those who are HIV positive and those who use drugs (as well as those with mental health problems where there may well be overlap) are anything from two to four times higher than the general adult smoking rates of most developed countries. One study of those receiving opiate substitute treatment recorded a smoking prevalence rate of 85%. Why should this be?
Harry’s blog 130: Follow the science not the money
For the sake of public health, end virtue signalling about THR funding
I arrived into the world of tobacco harm reduction (THR) from drugs and HIV harm reduction in 2015. I was invited into KAC by two valued colleagues from my previous world who were perfectly up front (and have never hidden the fact) that the funding for the organisation came from the Foundation for a Smoke Free World which in turn was funded by Philip Morris International. And the reason that they were prepared to use this money to further the cause of THR was that no other prospective funders for a harm reduction project were interested. Nobody back in the day was excited by the fact that if you could separate nicotine use from combustion the relative risk was massively reduced and the potential health gains enormous.